Department of Psychiatry, University of Iowa, Iowa City, IA; Department of Internal Medicine, University of Iowa, Iowa City, IA.
Division of Rheumatology, Department of Medicine, National Jewish Health, Denver, CO.
Chest. 2023 Feb;163(2):292-302. doi: 10.1016/j.chest.2022.09.022. Epub 2022 Sep 24.
Studies have shown that COPD and smoking are associated with increased suicide risk. To date, there are no prospective studies examining suicide risk among individuals with smoking exposure along a spectrum of pulmonary diseases ranging from normal spirometry to severe COPD.
Which clinical variables predict death by suicide or overdose of indeterminate intent in a large cohort of individuals with smoking exposure within the Genetic Epidemiology of COPD (COPDGene) study?
We studied data from 9,930 participants involved in COPDGene, a multisite, prospective cohort study of individuals with smoking exposure. Primary cause of adjudicated deaths was identified by using death certificates, family reports, and medical records. Time to death by suicide/overdose was examined as the primary outcome in Cox regression models including age, sex, race, BMI, pack-years, current smoking status, airflow limitation (FEV % predicted), dyspnea (modified Medical Research Council scale score ≥ 2), 6-min walk distance, supplemental oxygen use, and severe exacerbations in the prior year with time-varying covariates and other causes of death as a competing risk.
The cohort was 47% female and 33% Black (67% White); they had a mean ± SD age of 59.6 ± 9.0 years and a mean FEV % predicted of 76.1 ± 25.5. Sixty-three individuals died by suicide/overdose. Factors associated with risk of suicide/overdose were current smoking (hazard ratio [HR], 6.44; 95% CI, 2.64-15.67), use of sedative/hypnotics (HR, 2.33; 95% CI, 1.24-4.38), and dyspnea (HR, 2.23; 95% CI, 1.34-3.70). Lower risk was associated with older age (per-decade HR, 0.45; 95% CI, 0.31-0.67), higher BMI (HR, 0.95; 95% CI, 0.91-0.99), and African-American race (HR, 0.41; 95% CI, 0.23-0.74). Severity of airflow limitation (FEV % predicted) was not associated with suicide risk.
In this well-characterized cohort of individuals with smoking exposure with and without COPD, risk factors for suicide/overdose were identified that emphasize the subjective experience of illness over objective assessments of lung function.
研究表明,COPD 和吸烟与自杀风险增加有关。迄今为止,尚无前瞻性研究在从正常肺功能到严重 COPD 等一系列肺部疾病中检查吸烟暴露个体的自杀风险。
在大规模吸烟暴露个体的遗传流行病学 COPD(COPDGene)研究中,哪些临床变量可预测因自杀或不确定意图过量服药而死亡?
我们研究了 COPDGene 多中心前瞻性队列研究中 9930 名参与者的数据,这些参与者有吸烟暴露史。主要死因通过死亡证明、家庭报告和病历确定。使用 Cox 回归模型检查自杀/过量服药的死亡时间作为主要结局,该模型包括年龄、性别、种族、BMI、吸烟包年数、当前吸烟状态、气流受限(FEV % 预测值)、呼吸困难(改良医学研究理事会呼吸困难量表评分≥2)、6 分钟步行距离、吸氧以及前一年严重加重的情况,并随着时间变化的协变量和其他死亡原因作为竞争风险。
队列中 47%为女性,33%为黑人(67%为白人);平均年龄为 59.6±9.0 岁,平均 FEV % 预测值为 76.1±25.5。63 人死于自杀/过量服药。与自杀/过量服药风险相关的因素包括当前吸烟(危险比 [HR],6.44;95%可信区间,2.64-15.67)、镇静/催眠药物使用(HR,2.33;95%可信区间,1.24-4.38)和呼吸困难(HR,2.23;95%可信区间,1.34-3.70)。年龄较大(每十年 HR,0.45;95%可信区间,0.31-0.67)、BMI 较高(HR,0.95;95%可信区间,0.91-0.99)和非裔美国人种族(HR,0.41;95%可信区间,0.23-0.74)与较低风险相关。气流受限严重程度(FEV % 预测值)与自杀风险无关。
在这项对有和无 COPD 的吸烟暴露个体进行了充分特征描述的队列研究中,确定了自杀/过量服药的危险因素,这些危险因素强调了疾病的主观体验,而不是对肺功能的客观评估。